New functionalities in Orphanet for orphan drugs, R&D and marketing authorisations to better serve the rare diseases community
- DOI
- 10.1186/1750-1172-5-s1-p25
- Published
- 2010-10
- Container
- Orphanet Journal of Rare Diseases
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1186/1750-1172-5-s1-p25,
title = {New functionalities in Orphanet for orphan drugs, R\&D and marketing authorisations to better serve the rare diseases community},
author = {Virginie Hivert and Natalia Martin and Marc Hanauer and Ségolène Aymé},
year = {2010},
journal = {Orphanet Journal of Rare Diseases},
doi = {10.1186/1750-1172-5-s1-p25},
url = {https://doi.org/10.1186/1750-1172-5-s1-p25}
}RIS
TY - JOUR TI - New functionalities in Orphanet for orphan drugs, R&D and marketing authorisations to better serve the rare diseases community AU - Virginie Hivert AU - Natalia Martin AU - Marc Hanauer AU - Ségolène Aymé PY - 2010 JO - Orphanet Journal of Rare Diseases DO - 10.1186/1750-1172-5-s1-p25 UR - https://doi.org/10.1186/1750-1172-5-s1-p25 ER -
APA
Hivert, V., Martin, N., Hanauer, M., & Aymé, S. (2010). New functionalities in Orphanet for orphan drugs, R&D and marketing authorisations to better serve the rare diseases community. Orphanet Journal of Rare Diseases. https://doi.org/10.1186/1750-1172-5-s1-p25
Source records
- crossref · retrieved 2026-09-26T04:53:13.895Z